Search results
Why Moderna (MRNA) Stock Price Was Up 13% on Tuesday
Zacks via Yahoo Finance· 5 months agoShares of COVID-19 vaccine maker Moderna MRNA rose 13.1% on Jan 2, after analysts at Oppenheimer recently upgraded the stock’s recommendation to...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 1 month agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Why Moderna Stock Rose Today
Motley Fool· 2 years agoShares of Moderna (NASDAQ: MRNA) climbed 2.9% on Tuesday after fellow COVID-19 vaccine maker Pfizer (NYSE: PFE) boosted its full-year sales and profit...
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 1 year agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoIn the latest trading session, Moderna (MRNA) closed at $171.48, marking a +1.3% move from the...
Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 3 months agoModerna (MRNA) witnessed a jump in share price last session on above-average trading volume. The...
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
Zacks via Yahoo Finance· 1 year agoModerna MRNA reported earnings of 19 cents per share for the first quarter of 2023, beating the...
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
Zacks via Yahoo Finance· 8 months agoIn the latest market close, Moderna (MRNA) reached $102.76, with a -1.6% movement compared to the...
Pfizer Quadruples Its Covid Shot Price — And Other Vaccine Stocks Rocket
Investor's Business Daily· 2 years agoModerna snagged an upgrade Friday on the likelihood it will follow in Pfizer's footsteps in hiking...
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA reported earnings of $5.24 per share for the second quarter of 2022, beating the...
